def analyze_tnbc_treatment_survival():
    """
    Analyzes clinical trial data to determine which patient population
    experiences prolonged overall survival with PD-1 inhibitors in TNBC.
    """

    # Representing key findings from pivotal clinical trials for metastatic TNBC.
    # A value of 'True' means a statistically significant Overall Survival (OS) benefit was observed.
    # A value of 'False' means no statistically significant OS benefit was observed.

    # KEYNOTE-355 trial (Pembrolizumab + Chemotherapy)
    # Benefit in the population with PD-L1 expression (Combined Positive Score [CPS] >= 10)
    pembrolizumab_pdl1_positive_benefit_cps_10 = True
    # Benefit in the overall Intention-to-Treat (ITT) population
    pembrolizumab_itt_population_benefit = False

    # IMpassion130 trial (Atezolizumab + Chemotherapy)
    # Benefit in the population with PD-L1+ tumors
    atezolizumab_pdl1_positive_benefit = True
    # Benefit in the overall Intention-to-Treat (ITT) population
    atezolizumab_itt_population_benefit = False # This endpoint was not met with statistical significance in the final analysis.

    print("### Analysis of Clinical Trial Data on Overall Survival in TNBC ###\n")
    print("This script programmatically represents the findings from key clinical trials.")

    conclusion = ""
    # The most consistent and significant benefit is observed when both trials show a positive result in the same subgroup.
    if atezolizumab_pdl1_positive_benefit and pembrolizumab_pdl1_positive_benefit_cps_10:
        conclusion = (
            "Based on the data, the addition of a PD-1/PD-L1 inhibitor to chemotherapy "
            "results in a prolonged overall survival primarily in the PD-L1-positive population.\n\n"
            "For example, in the KEYNOTE-355 trial, a significant benefit was seen in patients "
            "whose tumors were PD-L1-positive with a Combined Positive Score (CPS) of 10 or more.\n\n"
            "In contrast, a statistically significant overall survival benefit was not consistently demonstrated "
            "in the overall intention-to-treat (ITT) population across these major trials."
        )
    else:
        conclusion = "The data from clinical trials is inconclusive or does not point to a specific population."


    print(conclusion)
    print("\nTherefore, the correct choice is B: PD-L1-positive population.")
    # The prompt requests outputting numbers in a final equation.
    # As there is no mathematical equation, we highlight the key numerical value from the clinical trial.
    print("\n--- Key Numerical Value ---")
    key_value = 10
    print(f"The KEYNOTE-355 trial defined the highly responsive group with a CPS score >= {key_value}")


analyze_tnbc_treatment_survival()